Glycyrrhizin, a triterpenoid saponin from Glycyrrhiza glabra, has also been shown to ameliorate AD symptoms by inhibiting the pro-inflammatory mediator HMGB1, thereby reducing mast cell activation, Th2 cytokine production, and immune cell infiltration in AD mouse model [45]. This evidence concerns the gene HMGB1 and Alzheimer disease.